OA03386A - Dérivés de la phénothiazine et leur préparation. - Google Patents

Dérivés de la phénothiazine et leur préparation.

Info

Publication number
OA03386A
OA03386A OA53262A OA53262A OA03386A OA 03386 A OA03386 A OA 03386A OA 53262 A OA53262 A OA 53262A OA 53262 A OA53262 A OA 53262A OA 03386 A OA03386 A OA 03386A
Authority
OA
OAPI
Prior art keywords
preparation
phenothiazine derivatives
phenothiazine
derivatives
Prior art date
Application number
OA53262A
Other languages
English (en)
French (fr)
Original Assignee
Sandoz Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Sa filed Critical Sandoz Sa
Publication of OA03386A publication Critical patent/OA03386A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40—Oxygen atoms
    • C07D211/44—Oxygen atoms attached in position 4
    • C07D211/46—Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
OA53262A 1967-04-19 1968-04-19 Dérivés de la phénothiazine et leur préparation. OA03386A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH558967A CH497458A (de) 1967-04-19 1967-04-19 Verfahren zur Herstellung neuer Phenothiazin-Derivate
CH1705667 1967-12-05

Publications (1)

Publication Number Publication Date
OA03386A true OA03386A (fr) 1970-12-15

Family

ID=25698043

Family Applications (1)

Application Number Title Priority Date Filing Date
OA53262A OA03386A (fr) 1967-04-19 1968-04-19 Dérivés de la phénothiazine et leur préparation.

Country Status (17)

Country Link
US (1) US3531480A (he)
AT (2) AT293372B (he)
AU (2) AU5480273A (he)
BE (1) BE713802A (he)
BG (1) BG17326A3 (he)
CH (1) CH497458A (he)
DE (1) DE1770218A1 (he)
ES (1) ES352822A1 (he)
FR (1) FR1583822A (he)
GB (2) GB1223314A (he)
IE (2) IE32169B1 (he)
IL (2) IL36239A (he)
NL (1) NL6804983A (he)
NO (1) NO124997B (he)
OA (1) OA03386A (he)
RO (1) RO54395A (he)
SE (2) SE361884B (he)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3857943A (en) * 1969-03-27 1974-12-31 May & Baker Ltd New phenothiazine derivatives in the treatment of spasticity of muscles
CH511886A (de) * 1969-07-08 1971-08-31 Sandoz Ag Verfahren zur Herstellung neuer Furanonderivate
US20040259866A1 (en) * 1998-06-30 2004-12-23 Snutch Terrance P. Calcium channel blockers comprising two benzhydril moieties
US6310059B1 (en) * 1998-06-30 2001-10-30 Neuromed Technologies, Inc. Fused ring calcium channel blockers
CA2651811A1 (en) * 2006-05-11 2007-11-22 Neuromed Pharmaceuticals Ltd. Method for increasing the bioavailability of benzhydryl piperazine containing compounds
BR112013022788A2 (pt) 2011-03-08 2016-12-06 Zalicus Pharmaceuticals Ltd "composição farmacêutica compreendendo uma dispersão sólida de 1-(4-benzidrilpiperazin-1-il)-3,3-difenilpropan-1-ona"
US8409560B2 (en) 2011-03-08 2013-04-02 Zalicus Pharmaceuticals Ltd. Solid dispersion formulations and methods of use thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1212031A (fr) * 1957-10-21 1960-03-21 Rhone Poulenc Sa Dérivés de la phénothiazine substitués à l'azote par une chaîne basique comportant un hétérocycle et leur préparation

Also Published As

Publication number Publication date
BG17326A3 (he) 1973-07-25
IL29842A (he) 1971-05-26
DE1770218A1 (de) 1971-10-14
IL36239A (he) 1971-06-23
IL29842A0 (en) 1968-06-20
IE32169L (en) 1968-10-19
CH497458A (de) 1970-10-15
AU5480173A (en) 1973-07-12
SE356520B (he) 1973-05-28
IE32169B1 (en) 1973-05-02
ES352822A1 (es) 1969-11-16
AT293372B (de) 1971-10-11
IE32170L (en) 1968-10-19
AT292726B (de) 1971-09-10
FR1583822A (he) 1969-12-05
NL6804983A (he) 1968-10-21
SE361884B (he) 1973-11-19
AU5480273A (en) 1973-07-12
GB1223314A (en) 1971-02-24
BE713802A (he) 1968-10-17
RO54395A (he) 1973-02-17
NO124997B (he) 1972-07-03
GB1223315A (en) 1971-02-24
IE32170B1 (en) 1973-05-02
US3531480A (en) 1970-09-29

Similar Documents

Publication Publication Date Title
OA03386A (fr) Dérivés de la phénothiazine et leur préparation.
FR1522688A (fr) Dérivés de la phénothiazine et leur préparation
MC624A1 (fr) Dérivés de l'isoquinoleine et leur préparation
FR1502346A (fr) Dérivés de la guanidine et leur préparation
FR1505967A (fr) Dérivés de la thiéno-benzo-thiazépine et leur préparation
OA02879A (fr) Benzènesulfonyl-semicarbazides et leur préparation.
FR1530040A (fr) Dérivés de la pipérazine et leur préparation
FR90403E (fr) Nouveaux dérivés de la phénothiazine et leur préparation
FR1417995A (fr) Dérivés de la diéthylamine et leur préparation
FR1514737A (fr) Dérivés de la morpholine et leur préparation
FR1438225A (fr) Dérivés de la benzothiazine et leur préparation
OA02593A (fr) Dérivés de la phénothiazine et leur préparation.
FR1502224A (fr) Dérivés de la phénothiazine et leur préparation
FR1545887A (fr) Dérivés de l'indole et leur préparation
FR1483748A (fr) Nouveaux dérivés de la phénothiazine et leur préparation
FR1442299A (fr) Nouveaux dérivés de la phénothiazine et leur préparation
FR1510258A (fr) Dérivés de la tétrahydroquinoléine et leur préparation
FR1520778A (fr) Dérivés de tétracyclines et leur préparation
FR1521950A (fr) Dérivés de la phénothiazine, leur préparation et leurs applications
FR1522566A (fr) Dérivés de la pipéridine et leur préparation
FR1504026A (fr) Dérivés de la 1.2alpha-méthylène-19-nor-testostérone et leur préparation
FR1530039A (fr) Dérivés de la théophylline et leur préparation
FR1526188A (fr) Dérivés de diphényl alcanes et leur préparation
FR91008E (fr) Nouveaux dérivés de la phénothiazine et leur préparation
FR1466666A (fr) Nouveaux dérivés de la phénothiazine et leur préparation